Judy Naake, the founder of St Tropez Tan and all round successful businesswoman, has been announced as a keynote speaker at this year's VCT & EIS Investor Fourm on 30th November in London.

Enterprise Investment Partners (EIP) and Start Up Funding Club (SFC) have announced the launch of the SFC SEIS Fund, a new generalist SEIS Fund targeting a portfolio of primarily early stage SEIS companies across all sectors with strong growth and compelling exit prospects.

A Devon based social enterprise Action To Prevent Suicide CIC, is the fifth organisation to receive a £10,000 launchpad loan from the Health & Wellbeing Challenge Fund (South West) (H&WCF), managed by social investment company Resonance. The £10K unsecured loan will allow the enterprise to build capacity, take on further staff and increase their order book, enabling them to draw further investment from the Fund in the future.

A leading Birmingham enterprise is celebrating after securing £100,000 of SITR (Social Investment Tax Relief) investment from social investment company Resonance to help it expand its ‘upcycling’ venture.

This is the first investment from the Resonance West Midlands SITR Fund, launched earlier this year with £1.25m initial investment dedicated to providing affordable finance to social enterprises committed to dismantling poverty in the region.

IP Investment Management (HK) Ltd and Maven Capital Partners have sold a portfolio of two newly developed purpose-built student accommodation assets totaling 360 beds to Kumpulan Wang Persaraan (Diperbadankan) and 90 North Real Estate Partners. The portfolio consists of The Mill House (Edinburgh) and 800 Bristol Road (Selly Oak, Birmingham). Both assets are fully operational and will offer a day one running yield.

ibis Styles Glasgow Centre West has opened in Glasgow’s International Financial Services District following an £11.25 million investment led by the UK-based private equity and property manager, Maven Capital Partners. The hotel has been funded by Maven’s co-investor network ‘Investor Partners’, with a bank facility provided Allied Irish Bank.

Reasons why you should not miss the Forum on 30th November.  Plus you can get £30 off tickets until 31 August.

Click HERE to get yours

Join us f

UK's trade legacy is fintech charged, Brexit must be a springboard for international finance and trade or it could spell disaster says IW Capital. 

Ascension has partnered with India based Unicorn India Ventures to launch the first cross border EIS fund between the two countries. The Unicorn Ascension Fund (UAF) will invest in UK-based technology businesses, which can offer their products and services to the rapidly digitising economy in India. 

The Enterprise Investment Scheme Association (EISA) has released a national and investor representative piece of research, gauging whether the British public and its investors feel that they will be wealthier in a post-Brexit UK, and how they feel the negotiations have gone. 

Triple Point, which provides innovative and compelling investment solutions for private and institutional investors, announces the first investment of its Impact EIS managed service of up to £250,000 in MWS Technology, a company that is transforming the efficiency and compliance of organisations that deliver apprenticeship training through its Software-as-a-Service (SaaS) platform Aptem.

The investment will support the growth of MWS, significantly increasing its workforce and helping to develop Aptem, the only end-to-end technology platform software that can deliver the functionality required for forward-thinking training providers.

Calculus Capital, the award-winning Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist, has invested £2m in Oxford BioTherapeutics (OBT), a clinical-stage oncology company that is developing next-generation cancer treatments. OBT has a strong pipeline of ‘immune-oncology’ (IO) therapies that are intended to provide more targeted, specialised treatment strategies for patients by recruiting the body’s immune system to recognise and attack cancer cells.